Nitazoxanide
Therapeutic Category:
Anti Diarrheal
Disrupts parasite cellular metabolism; mechanism unclear
Primary Use:
GI nematodes and tapeworms in dogs
Ancylostoma, Toxocara, Uncinaria, Taenia spp.
Target Species:
Commercial
Status:
Commercial
Monograph:
In House, USP Pending Monograph
Regulatory Status:
DMF
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.